SAM
RCEL icon

Silvercrest Asset Management’s Avita Medical RCEL Stock Holding History

Silvercrest Asset Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-241,665
Closed -$3.87M – 935
2024
Q1 		$3.87M Buy
+241,665
New +$3.91M 0.03% 432
2020
Q4 		– Sell
-102,236
Closed -$2.57M – 830
2020
Q3 		$2.57M Buy
+102,236
New +$2.55M 0.02% 435

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Silvercrest Asset Management's RCEL Position: Q2 2024 in Review

Silvercrest Asset Management sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 241,665 shares — an estimated $3.87M sold.

Silvercrest Asset Management first reported a position in RCEL in Q3 2020 and held it in 2 quarters. The position peaked at $3.87M in Q1 2024. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Silvercrest Asset Management reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Silvercrest Asset Management sold 241,665 Avita Medical shares in Q2 2024, an estimated $3.87M.
  • Silvercrest Asset Management first reported a position in Avita Medical in Q3 2020 and held it in 2 quarters.
  • Silvercrest Asset Management's Avita Medical position peaked at $3.87M in Q1 2024.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Silvercrest Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.